US SB2032 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Engrossed on December 16 2020 - 50% progression, died in chamber
Action: 2020-12-16 - Held at the desk.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on December 16 2020 - 50% progression, died in chamber
Action: 2020-12-16 - Held at the desk.
Text: Latest bill text (Engrossed) [PDF]
Summary
Modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.
Title
Cannabidiol and Marihuana Research Expansion Act
Sponsors
| Sen. Dianne Feinstein [D-CA] | Sen. Chuck Grassley [R-IA] | Sen. Brian Schatz [D-HI] | Sen. Richard Durbin [D-IL] |
| Sen. Amy Klobuchar [D-MN] | Sen. Thom Tillis [R-NC] | Sen. Tim Kaine [D-VA] | Sen. Joni Ernst [R-IA] |
| Sen. Kevin Cramer [R-ND] | Sen. Lamar Alexander [R-TN] | Sen. Jon Tester [D-MT] | Sen. Lisa Murkowski [R-AK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-12-16 | House | Held at the desk. |
| 2020-12-16 | House | Received in the House. |
| 2020-12-16 | Senate | Message on Senate action sent to the House. |
| 2020-12-15 | Senate | Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507) |
| 2020-12-15 | Senate | S.Amdt.2708 Amendment SA 2708 agreed to in Senate by Unanimous Consent. |
| 2020-12-15 | Senate | S.Amdt.2708 Amendment SA 2708 proposed by Senator Sasse for Senator Feinstein. (consideration: CR S7508; text: CR S7504-7507) In the nature of a substitute. |
| 2020-12-15 | Senate | Measure laid before Senate by unanimous consent. (consideration: CR S7508) |
| 2020-12-15 | Senate | Senate Committee on the Judiciary discharged by Unanimous Consent. |
| 2019-10-23 | Senate | Committee on United States Senate Caucus on International Narcotics Control. Hearings held. |
| 2019-06-27 | Senate | Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634) |
Subjects
Congressional oversight
Crime and law enforcement
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Health programs administration and funding
Licensing and registrations
Medical research
Public-private cooperation
Research administration and funding
Trade restrictions
Crime and law enforcement
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Health programs administration and funding
Licensing and registrations
Medical research
Public-private cooperation
Research administration and funding
Trade restrictions
